Pennsylvania Senate passes prior-authorization biosimilar bill
HARRISBURG, Pa. — Pharmacists in Pennsylvania may soon be required to notify physicians prior to substituing a biologic medicine with a biosimilar medication following the passing of a bill by the Pennsylvania Senate, the Associated Press reported Tuesday.
The bill, sponsored by Sen. Pat Vance, R-District 31, was passed by a 44-to-6 vote.
The Insurance Federation of Pennsylvania and the Pennyslvania Pharmacists Association stand opposed to the proposed legislation, the AP reported.
